Gene expression profiling of tuberculous meningitis co-infected with HIV

Journal of Proteomics and Bioinformatics

Volumn 5, Issue 9, 2012, Pages 235-244

  Sameer Kumar, Ghantasala S ^a,b   Venuaopal, Abhilash K ^a,b,c   Kashvap, Manoi Kumar ^a   Raiu, Raiesh ^a   Marimuthu, Arivusudar ^a   Palapetta, Shvam Mohan ^a,d   Subbanayya, Yashwanth ^a,e   Goel, Renu ^a,b   Chawla, Ankit ^f   Dikshit, Jyoti Bajpai ^g   Tata, Pramila ^g   Harsha, H C ^a   Maharudraiah, Jagadeesha ^a   Ramachandra, Y L ^b   Satishchandra, Parthasarathy ^h   Keshava Prasad, T S ^a,d,i   Pandey, Akhilesh ^c   Mahadevan, Anita ^h   Shankar, S K ^h  

^a Institute of Bioinformatics   (India)

^b KUVEMPU UNIVERSITY   (India)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d PONDICHERRY UNIVERSITY   (India)

^e RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES   (India)

^f ARMED FORCES MEDICAL COLLEGE   (India)

^g Strand Life Sciences ^*  (India)

^h NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

ⁱ MANIPAL UNIVERSITY   (India)

Author keywords

Cerebrospinal fluid; Early diagnosis; GeneSpring; Neurological disorder; Single color labeling

Indexed keywords

BIOLOGICAL MARKER; DNA; GLIAL FIBRILLARY ACIDIC PROTEIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 8; SERINE PROTEINASE INHIBITOR; THYMIDINE PHOSPHORYLASE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN REGION; CONTROLLED STUDY; DNA MICROARRAY; ECGF1 GENE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE PRODUCT; GFAP GENE; HSPA8 GENE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; SERPINA3 GENE; TUBERCULOUS MENINGITIS; TYMP GENE;

EID: 84867667525     PISSN: None     EISSN: 0974276X     Source Type: Journal    
DOI: 10.4172/Jpb.1000243     Document Type: Article

References (89)

1. Fanning A (1999) Tuberculosis: 6. Extrapulmonary disease. CMAJ 160: 1597-1603.
2. Garg RK (1999) Tuberculosis of the central nervous system. Postgrad Med J 75: 133-140.
3. Hosoglu S, Geyik MF, Balik I, Aygen B, Erol S, et al. (2002) Predictors of outcome in patients with tuberculous meningitis. Int J Tuberc Lung Dis 6: 64-70.
4. Sheu JJ, Yuan RY, Yang CC (2009) Predictors for outcome and treatment delay in patients with tuberculous meningitis. Am J Med Sci 338: 134-139.
5. Eintracht S, Silber E, Sonnenberg P, Koornhof HJ, Saffer D (2000) Analysis of adenosine deaminase isoenzyme-2 (ADA(2) in cerebrospinal fluid in the diagnosis of tuberculosis meningitis. J Neurol Neurosurg Psychiatry 69: 137-138.
6. Garg SK, Tiwari RP, Tiwari D, Singh R, Malhotra D, et al. (2003) Diagnosis of tuberculosis: available technologies, limitations, and possibilities. J Clin Lab Anal 17: 155-163.
7. Juan RS, Sanchez-Suarez C, Rebollo MJ, Folgueira D, Palenque E, et al. (2006) Interferon gamma quantification in cerebrospinal fluid compared with PCR for the diagnosis of tuberculous meningitis. J Neurol 253: 1323-1330.
8. Donald PR, Malan C (1985) Cerebrospinal fluid lactate and lactate dehydrogenase levels as diagnostic aids in tuberculous meningitis. S Afr Med J 67: 19-20.
9. Gautam N, Aryal M, Bhatta N, Bhattacharya SK, Baral N, et al. (2007) Comparative study of cerebrospinal fluid adenosine deaminase activity in patients with meningitis. Nepal Med Coll J 9: 104-106.
10. Tang LM (1988) Serial lactate determinations in tuberculous meningitis. Scand J Infect Dis 20: 81-83.
11. control: Gt (2007) surveillance, planning, financing. World Health Organization, Geneva, Switzerland
12. Waaler HT (2002) Tuberculosis and poverty. Int J Tuberc Lung Dis 6: 745-746.
13. Raviglione MC, Snider DE Jr, Kochi A (1995) Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 273: 220-226.
14. Hira SK, Dupont HL, Lanjewar DN, Dholakia YN (1998) Severe weight loss: the predominant clinical presentation of tuberculosis in patients with HIV infection in India. Natl Med J India 11: 256-258.
15. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, et al (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163: 1009-1021.
16. De Cock K (1994) The new tuberculosis. Afr Health 16: 8-10.
17. Farer LS, Lowell AM, Meador MP (1979) Extrapulmonary tuberculosis in the United States. Am J Epidemiol 109: 205-217.
18. Garg RK, Sinha MK (1992) Tuberculous meningitis in patients infected with the human immunodeficiency virus. J Neurol 326: 668-672.
19. Dube MP, Holtom PD, Larsen RA (1992) Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med 93: 520-524.
20. Rana FS, Hawken MP, Mwachari C, Bhatt SM, Abdullah F, et al. (2000) Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya. J Acquir Immune Defic Syndr 24: 23-29.
21. Azuaje C, Fernandez Hidalgo N, Almirante B, Martin-Casabona N, Ribera E, et al. (2006) [Tuberculous meningitis: a comparative study in relation to concurrent human immunodeficiency virus infection]. Enferm Infecc Microbiol Clin 24: 245-250.
22. Thwaites GE, Duc Bang N, Huy Dung N, Thi Quy H, Thi Tuong Oanh D, et al. (2005) The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with Tuberculous meningitis. J Infect Dis 192: 2134-2141.
23. McArthur JC (1987) Neurologic manifestations of AIDS. Medicine 66: 407-437.
24. Price RW (1996) Neurological complications of HIV infection. Lancet 348: 445-452.
25. Simpson DM, Berger JR (1996) Neurologic manifestations of HIV infection. Med Clin North Am 80: 1363-1394.
26. MJ HM (1995) AIDS and Neurology. 12-30
27. Sidtis JJ, Price RW (1990) Early HIV-1 infection and the AIDS dementia complex. Neurology 40: 323-326.
28. Horn DL, Hewlett D Jr, Peterson S, Sabido D, Opal SM (1993) RISE-resistant tuberculous meningitis in AIDS patient. Lancet 341: 177-178.
29. Thwaites GE, Chau TT, Farrar JJ (2004) Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol 42: 378-379.
30. Katrak SM, Shembalkar PK, Bijwe SR, Bhandarkar LD (2000) The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. J Neurol Sci 181: 118-126.
31. Offiah CE, Turnbull IW (2006) The imaging appearances of intracranial CNS infections in adult HIV and AIDS patients. Clin Radiol 61: 393-401.
32. Smego RA Jr, Orlovic D, Wadula J (2006) An algorithmic approach to intracranial mass lesions in HIV/AIDS. Int J STD AIDS 17: 271-276.
33. Bekedam HJ, Boeree M, Kamenya A, Liomba G, Ngwira B, et al. (1997) Tuberculous lymphadenitis, a diagnostic problem in areas of high prevalence of HIV and tuberculosis. Trans R Soc Trop Med Hyg 91: 294-297.
34. Kumar GSS, Venugopal AK, Selvan LDN, Marimuthu A, Keerthikumar S, et al. (2011) Gene Expression Profiling of Tuberculous Meningitis. Journal of Proteomics and Bioinformatics 4: 98-105.
35. Ahmed HG, Nassar AS, Ginawi I (2011) Screening for tuberculosis and its histological pattern in patients with enlarged lymph node. Patholog Res Int 2011: 417635.
36. Siddappa NB, Dash PK, Mahadevan A, Jayasuryan N, Hu F, et al. (2004) Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India. J Clin Microbiol 42: 2742-2751.
37. Kashyap MK, Marimuthu A, Kishore CJ, Peri S, Keerthikumar S, et al. (2009) Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers. Cancer Biol Ther 8: 36-46.
38. Marimuthu A, Jacob HKC, Jakharia A, Subbannayya Y, Keerthikumar S, et al. (2011) Gene expression profiling of gastric cancer. Journal of Proteomics and Bioinformatics 4: 74-82.
39. Venugopal AK, Kumar GSS, Mahadevan A, Selvan LDN, Marimuthu A, et al. (2012) Transcriptomic Profiling of Medial Temporal Lobe Epilepsy. J Proteomics and Bioinform 5: 031-039.
40. Goel R, Muthusamy B, Pandey A, Prasad TS (2011) Human protein reference database and human proteinpedia as discovery resources for molecular biotechnology. Mol Biotechnol 48: 87-95.
41. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, et al. (2009) Human Protein Reference Database--2009 update. Nucleic Acids Res 37: D767-772.
42. Colton CA, Mott RT, Sharpe H, Xu Q, Van Nostrand WE, et al. (2006) Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation 3: 27.
43. Kim DK, Park GM, Hwang YI, Kim HJ, Han SK, et al. (2006) Microarray analysis of gene expression associated with extrapulmonary dissemination of tuberculosis. Respirology 11: 557-565.
44. Rehli M, Krause SW, Andreesen R (1997) Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics 43: 221-225.
45. Kingsbury GA, Feeney LA, Nong Y, Calandra SA, Murphy CJ, et al. (2001) Cloning, expression, and function of BLAME, a novel member of the CD2 family. J Immunol 166: 5675-5680.
46. Lee LN, Baban D, Ronan EO, Ragoussis J, Beverley PC, et al. (2010) Chemokine gene expression in lung CD8 T cells correlates with protective immunity in mice immunized intra-nasally with Adenovirus-85A. BMC Med Genomics 3: 46.
47. Gonzalez-Juarrero M, Kingry LC, Ordway DJ, Henao-Tamayo M, Harton M, et al. (2009) Immune response to Mycobacterium tuberculosis and identification of molecular markers of disease. Am J Respir Cell Mol Biol 40:398-409.
48. Chang CH, Fontes JD, Peterlin M, Flavell RA (1994) Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med 180: 1367-1374.
49. Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B (1994) Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265: 106-109.
50. Keller C, Hoffmann R, Lang R, Brandau S, Hermann C, et al. (2006) Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes. Infect Immun 74: 4295-4309.
51. El Chartouni C, Rehli M (2010) Comprehensive analysis of TLR4-induced transcriptional responses in interleukin 4-primed mouse macrophages. Immunobiology 215: 780-787.
52. Yue FY, Lo C, Sakhdari A, Lee EY, Kovacs CM, et al. (2010) HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control. J Immunol 185: 498-506.
53. Draper DW, Bethea HN, He YW (2006) Toll-like receptor 2-dependent and -independent activation of macrophages by group B streptococci. Immunol Lett 102: 202-214.
54. Zaleznik DF, Rench MA, Hillier S, Krohn MA, Platt R, et al. (2000) Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis 30: 276-281.
55. Mehra S, Pahar B, Dutta NK, Conerly CN, Philippi-Falkenstein K, et al. (2010) Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas. PLoS One 5: e12266.
56. Beisiegel M, Mollenkopf HJ, Hahnke K, Koch M, Dietrich I, et al. (2009) Combination of host susceptibility and Mycobacterium tuberculosis virulence define gene expression profile in the host. Eur J Immunol 39: 3369-3384.
57. Takahashi S, Cui YH, Han YH, Fagerness JA, Galloway B, et al. (2008) Association of SNPs and haplotypes in APOL1, 2 and 4 with schizophrenia. Schizophr Res 104: 153-164.
58. Abraham CR, Selkoe DJ, Potter H (1988) Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52: 487-501.
59. DeKosky ST, Ikonomovic MD, Wang X, Farlow M, Wisniewski S, et al. (2003) Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment. Ann Neurol 53: 81-90.
60. Licastro F, Parnetti L, Morini MC, Davis LJ, Cucinotta D, et al. (1995) Acute phase reactant alpha 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease. Alzheimer Dis Assoc Disord 9: 112-118.
61. Kawahara A, Hattori S, Akiba J, Nakashima K, Taira T, et al. (2010) Infiltration of thymidine phosphorylase-positive macrophages is closely associated with tumor angiogenesis and survival in intestinal type gastric cancer. Oncol Rep 24: 405-415.
62. Blondon H, Polivka M, Joly F, Flourie B, Mikol J, et al. (2005) Digestive smooth muscle mitochondrial myopathy in patients with mitochondrial-neuro-gastro-intestinal encephalomyopathy (MNGIE). Gastroenterol Clin Biol 29: 773-778.
63. Asai K, Nakanishi K, Isobe I, Eksioglu YZ, Hirano A, et al. (1992) Neurotrophic action of gliostatin on cortical neurons. Identity of gliostatin and platelet-derived endothelial cell growth factor. J Biol Chem 267: 20311-20316.
64. Campbell DB, Lange LA, Skelly T, Lieberman J, Levitt P, et al. (2008) Association of RGS2 and RGS5 variants with schizophrenia symptom severity. Schizophr Res 101: 67-75.
65. Smith EN, Bloss CS, Badner JA, Barrett T, Belmonte PL, et al. (2009) Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry 14: 755-763.
66. Bacchelli E, Blasi F, Biondolillo M, Lamb JA, Bonora E, et al. (2003) Screening of nine candidate genes for autism on chromosome 2q reveals rare nonsynonymous variants in the cAMP-GEFII gene. Mol Psychiatry 8: 916-924.
67. Okino N, He X, Gatt S, Sandhoff K, Ito M, et al. (2003) The reverse activity of human acid ceramidase. J Biol Chem 278: 29948-29953.
68. Koch J, Gartner S, Li CM, Quintern LE, Bernardo K, et al. (1996) Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. Identification Of the first molecular lesion causing Farber disease. J Biol Chem 271: 33110-33115.
69. Guarguaglini G, Duncan PI, Stierhof YD, Holmstrom T, Duensing S, et al. (2005) The forkhead-associated domain protein Cep170 interacts with Polo-like kinase 1 and serves as a marker for mature centrioles. Mol Biol Cell 16: 1095-1107.
70. Jin J, Smith FD, Stark C, Wells CD, Fawcett JP, et al. (2004) Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol 14: 1436-1450.
71. Lee MJ, Van Brocklyn JR, Thangada S, Liu CH, Hand AR, et al. (1998) Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279: 1552-1555.
72. Hla T, Maciag T (1990) An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J Biol Chem 265: 9308-9313.
73. Potkin SG, Guffanti G, Lakatos A, Turner JA, Kruggel F, et al. (2009) Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PLoS One 4: e6501.
74. Tassan JP, Jaquenoud M, Leopold P, Schultz SJ, Nigg EA (1995) Identification of human cyclin-dependent kinase 8, a putative protein kinase partner for cyclin C. Proc Natl Acad Sci U S A 92: 8871-8875.
75. Goytain A, Hines RM, El-Husseini A, Quamme GA (2007) NIPA1(SPG6), the basis for autosomal dominant form of hereditary spastic paraplegia, encodes a functional Mg2+ transporter. J Biol Chem 282: 8060-8068.
76. Szolnoki Z, Kondacs A, Mandi Y, Somogyvari F (2007) A cytoskeleton motor protein genetic variant may exert a protective effect on the occurrence of multiple sclerosis: the janus face of the kinesin light-chain 1 56836CC genetic variant. Neuromolecular Med 9: 335-339.
77. Andersson ME, Sjolander A, Andreasen N, Minthon L, Hansson O, et al. (2007) Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease. Int J Mol Med 20: 233-239.
78. Andersson ME, Zetterberg M, Tasa G, Seibt-Palmer M, Juronen E, et al. (2007) Variability in the kinesin light chain 1 gene may influence risk of age-related cataract. Mol Vis 13: 993-996.
79. Martins-de-Souza D, Gattaz WF, Schmitt A, Maccarrone G, Hunyadi-Gulyas E, et al. (2009) Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. J Psychiatr Res 43: 978-986.
80. Martins-de-Souza D, Maccarrone G, Wobrock T, Zerr I, Gormanns P, et al. (2010) Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia. J Psychiatr Res 44: 1176-1189.
81. Kim JJ, Mandelli L, Lim S, Lim HK, Kwon OJ, et al. (2008) Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia. Eur Arch Psychiatry Clin Neurosci 258: 239-244.
82. Yang T, Hsu C, Liao W, Chuang JS (2008) Heat shock protein 70 expression in epilepsy suggests stress rather than protection. Acta Neuropathol 115: 219-230.
83. Blakely PK, Kleinschmidt-DeMasters BK, Tyler KL, Irani DN (2009) Disrupted glutamate transporter expression in the spinal cord with acute flaccid paralysis caused by West Nile virus infection. J Neuropathol Exp Neurol 68: 1061-1072.
84. Konakahara S, Suzuki Y, Kawakami T, Saitou M, Kajikawa M, et al. (2012) A neuronal transmembrane protein LRFN4 complexes with 14-3-3s and NCK1 to induce morphological change in monocytic cells via Rac1-mediated actin cytoskeleton reorganization. FEBS Lett 586: 2251-2259.
85. Zhao C, Sardella A, Chun J, Poubelle PE, Fernandes MJ, et al. (2011) TNF-alpha promotes LPA1- and LPA3-mediated recruitment of leukocytes in vivo through CXCR2 ligand chemokines. J Lipid Res 52: 1307-1318.
86. Morawski M, Bruckner G, Arendt T, Matthews RT (2012) Aggrecan: Beyond cartilage and into the brain. Int J Biochem Cell Biol 44: 690-693.
87. Chaudhuri A, Yang B, Gendelman HE, Persidsky Y, Kanmogne GD (2008) STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood 111: 2062-2072.
88. Blanpain C, Libert F, Vassart G, Parmentier M (2002) CCR5 and HIV infection. Receptors Channels 8: 19-31.
89. Jacobson JM, Thompson MA, Lalezari JP, Saag MS, Zingman BS, et al. (2010) Anti-HIV-1 activity of weekly or biweekly treatment with subcutaneous PRO 140, a CCR5 monoclonal antibody. J Infect Dis 201: 1481-1487.